On Today’s Sunday Soundbite we hear from Joseph Araujo (Chief Scientific Officer) talk to investors today about the exciting news that Mindset is now moving forward with plans for Clinical Trials of its Advanced Pre-Clinical Psychedelic, MSP-1014.  Find out what this means for the company as they advance to this monumental next stage!

About Mindset Pharma Inc: (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF)
Founded by domain experts in drug development, medicinal chemistry and capital markets, Mindset Pharma is a Toronto-based research and development company that utilizes a proprietary platform for discovering and developing novel and patentable next-generation psychedelic drug candidates for the treatment of neurological and psychiatric disorders.

For a Full Profile View & Press Release of Mindset Pharma Inc. Visit:
https://theinvestorscoliseum.com/featured-companies/mindset-pharma-inc/

Mindset Planning Trials for its Advanced Pre-Clinical Psychedelic MSP-1014!

Michael Edwards COO, Black Swan Graphene Inc.  Recaps and Explains Strategic Partnership with Nationwide Engineering Research and Development Ltd.
On Today’s Soundbite we hear from Michael Edwards, COO (Black Swan Graphene Inc.) talk to investors about the major milestones and Strategic Partnership with the Nationwide Engineering Research and Development Ltd. As he also introduces how both companies will be embedded in a fully integrated building materials supply chain aimed at accelerating the adoption of graphene-enhanced concrete globally. Very exciting times at Black Swan Graphene listen in!!!
About Black Swan Graphene Inc.
Black Swan Graphene Inc. is focused on the large-scale production and commercialization of patented high-performance and low-cost graphene products aimed at several industrial sectors, including concrete, polymers, Li-ion batteries, and others, which are expected to require large volumes of graphene. Black Swan aims to leverage the low cost and green hydroelectricity of the province of Québec as well as the proximity of the eventual graphite production sites of the province in order to establish a fully integrated supply chain, reduce overall costs, and accelerate the deployment of graphene usage. Black Swan’s graphene processing technology was developed by Thomas Swan & Co. Ltd (“Thomas Swan”) over the last decade. Thomas Swan is a United Kingdom-based global chemicals manufacturer, with a century-long track record and has been at the forefront of graphene innovation.

Please visit for a Full Profile view and Press Release of Black Swan Graphene Inc. please visit them at: https://theinvestorscoliseum.com/featured-companies/black-swan-graphene-inc-2/

Michael Edwards COO, Black Swan Graphene Inc.  Recaps and Explains Strategic Partnership

Canadian Copper Inc.  Simon Quick CEO, provides update and strategy for upcoming exploration campaign 2023.

On Today’s Soundbite we hear from Simon Quick (CEO, Canadian Copper Inc..) talk to investors about the major milestones and accomplishments achieved in 2022, and the systematic strategy put in place for the 2023 exploration campaign which is shaping up to be a very productive and busy. CCI is undervalued compared to its peers, based on current and growing in-situ copper resources relative to its market cap. Keep your eyes on CCI!!.

About Canadian Copper Inc.
Canadian Copper is a Canadian-based mineral exploration company with a copper and base metals portfolio of historical resources and grassroots projects. The Company is focused on the prolific Bathurst Mining Camp (BMC) of New Brunswick, Canada.

Canadian Copper Inc.  Simon Quick CEO, provides update & exploration strategy

On Today’s Soundbite we hear from Myke Clarke (CEO, Solar Alliance) talk to investors about their recent release of their audited financial results for the quarter and year ended December 31, 2022. “Solar Alliance continued to successfully execute on our strategy as our team delivered solid revenue growth during 2022,” said CEO Myke Clark. “Our transition to larger commercial and utility projects has resulted in strong growth and a substantial backlog of projects under contract, positioning us very well for 2023 and beyond.”
“During 2022, Solar Alliance made significant investments in our team, which resulted in a strong revenue growth profile. As a direct result of our investment over the last year, we have the ability to scale significantly with our current team. We are also committed to increasing project margins and ensuring our expenses are appropriate for our contracted project pipeline, as we target to achieve profitability in the coming quarters.” 
And find out what this means for the company going forward in 2023.

For a Full Profile View & Press Release of Solar Alliance Energy Visit: https://theinvestorscoliseum.com/featured-companies/solar-alliance-energy-inc/

Solar Alliance Revenue GROWS 31% in 2022 to $4.8 million: Commentary from CEO, Myke Clark

Update from EVP Corporate Development, Ian Parkinson on Emerita Resources Maiden Independent NI-43-101 Compliant Resource Estimate

On Today’s soundbite we hear from EVP Corporate Development, Ian Parkinson share with us a brief update on the recently released maiden independent NI 43-101 compliant resource estimate and its significance results, which was press released on March 23rd,2023. Exciting times at Emerita Resources, this story is definitely one to watch!!!

David Gower, P.Geo., CEO of Emerita stated, “The last 12 months have been a busy and exciting time for the Spain based Emerita exploration team. It is a credit of the team to be able to release our first NI 43-101 compliant resource estimate for the IBW project in a compressed time frame given drilling commenced on La Romanera only last summer. This represents an interim mineral resource estimate as work continues to expand the resources at IBW. The recent exploration mapping, drilling and geophysical surveys demonstrate both La Romanera and La Infanta remain open along strike and at depth. This coupled with targets associated with the recently expanded land position provides a lot of additional targets for new discoveries. Metallurgical test work is commencing which will inform a key component of a future economic study of IBW while we continue to explore.”

For a Full Profile View and Press Release  visit: https://theinvestorscoliseum.com/featured-companies/emerita-resources-corp-2/

Update from EVP Corporate Development, Ian Parkinson

On Today’s Soundbite we hear from Mindset Pharma CEO James Lanthier, with a brief update on the interesting trends they are seeing in the rapidly developing medical psychedelic market, and how their strategy, development plans and partnerships fit perfectly with the emerging direction of the market.  

James Lanthier Remarked: "While we are focused on the business rather than announcements at the moment, I can assure you that our work in advancing our new drug families is going exceptionally well.  From what we refer to as our “Family 2” series, as previously announced, our leads from that series are progressing through safety studies very well and we are making great progress towards advancing them to human trials.  We are continuing to make tremendous strides in moving multiple drug families forward and are the only psychedelic biotech in the market doing so with the assistance and funding from one of the world’s top psychiatric drug companies."

About Mindset Pharma Inc.
Mindset Pharma Inc. is a drug discovery and development company focused on creating optimized and patentable best-in-class innovative next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet needs. Mindset was established in order to develop next-generation pharmaceutical assets that leverage the breakthrough therapeutic potential of psychedelic drugs. Mindset is developing several novel families of next-generation psychedelic compounds, as well as an innovative process to chemically synthesize psilocybins in addition to its own proprietary compounds. The company has a co-development agreement with the McQuade Center for Strategic Research and Development, a member of the Otsuka Pharmaceuticals family of companies, covering multiple drug development programs.

Mindset Pharma Inc. CEO, James Lanthier Provides Update and Discusses Interesting Sector Trends.

On Today’s Featured Company Soundbite, we hear from Jim MacDonald (President, Levante Living Trust) speak to investors about its recently announced Partnership with Welltower.

“Effective September 1, 2023, Levante Living Group Inc (”Levante”) has entered into a management agreement with Welltower. Welltower is a real estate investment trust that invests in health care infrastructure. With over 40 years in the senior living/health care sector, Welltower was one of the first companies of its kind to invest in senior housing. They are a public company on the NYSE (WELL) with revenue of $4.7 billion, an enterprise value of $50 billion, and are the largest health care real estate investment trust (2021)

"Levante Living Group Inc is pleased to partner with Welltower. It is an opportunity for us to strengthen our track record and deepen our market penetration." We look forward to building on this partnership going forward."
--Michael Petersen, President & CEO of Levante Living Group Inc. 

ABOUT LEVANTE
Levante Living is a Canadian owned enterprise focused on acquiring, managing, and redeveloping senior housing in North America. We eagerly serve our residents, employees, and investors by focusing on dignity, compassion, integrity, and excellence in the marketplace.
Enhancing the lives of those we serve with dignity, compassion, integrity, and excellence.
With a cumulative 20 years in senior living sector, including the development, operations and redevelopment of long-term care facilities and adult based residential communities and over 30 years experience in financial services market, the team at Levante is working to change the landscape of healthcare in Canada.

For a Full Profile view of this Featured Company please visit: https://theinvestorscoliseum.com/featured-companies/Levante-Living-Trust/

Jim Macdonald Levante Living Trust October 2023

Update from EVP Corporate Development, Ian Parkinson of Emerita Resources discusses recently released drill results issued on October 10,2023

On Today’s soundbite we hear from EVP Corporate Development, Ian Parkinson share with us a brief update on the recently released drill results from the ongoing drilling program at La Romanera Deposit, part of Emerita’s wholly owned Iberian Belt West project (“IBW” or the “Project). IBW hosts three previously identified massive sulphide deposits: La Infanta, La Romanera and El Cura. Results contained in the release are from La Romanera deposit where drilling is tracing the extension of the deposit at depth. Listen In for his insights on these results!!

For a Full Profile View and Press Release  visit: https://theinvestorscoliseum.com/featured-companies/emerita-resources-corp-2/

Emerita Resources Ian Parkinson Update On Drilling

Sit-down with CEO and Director Ian Parkinson of Halcones Precious Metals.
I had the opportunity to sit-down with Ian Parkinson in New York City last week. Ian gives us an update on current operations at Halcones and some catalysts Investors and interested potential shareholders can expect from the company in the coming months. Don’t miss out, have a listen.

About Halcones Precious Metals Corp.
Halcones is focused on exploring for and developing gold-silver projects in the Maricunga Belt, Chile, the premiere gold mining district in South America. The Company has a team with a strong background of exploration success in the region.

Please visit: https://www.halconespreciousmetals.com/ 

 www.theinvestorscoliseum.com

Halcones Precious Metals CEO Ian Pakinson Update From NYC

Simon Quick, CEO Canadian Copper Inc. gives us an update and what to expect from the company in the coming months.

On Today’s Soundbite I had the opportunity in New York City to catch up with Simon Quick (CEO, Canadian Copper Inc.) talk to investors about update current operations at Canadian Copper Inc. and some catalysts Investors and interested shareholders can expect from the company in the coming months and a little insight on the overall copper markets. Listen in to find out the go forward strategy for CCI.

For a Full Profile View and Press Release: https://theinvestorscoliseum.com/featured-companies/canadian-copper-inc/

About Canadian Copper Inc.
Canadian Copper is a Canadian-based mineral exploration company with a copper and base metals portfolio of historical resources and grassroots projects. The Company is focused on the prolific Bathurst Mining Camp (BMC) of New Brunswick, Canada.

Canadian Copper Inc. CEO, Simon Quick Update And Insights

Update from EVP Corporate Development, Ian Parkinson of Emerita Resources Corp. 
March 14,2024 On Today’s Coliseum Quick Cast, we hear from EVP Corporate Development, Ian Parkinson discussing Emerita Resources Corp.  recently announced drill results, and some upcoming catalysts for the company in 2024 and beyond. 

For a Full Profile View and Press Release  visit: https://theinvestorscoliseum.com/featured-companies/emerita-resources-corp-2/

Ian Parkinson EVP Emerita Resources Drill Results Explained And Upcoming Catalyst 2024

Value Proposition

The Investors Coliseum was created for the diligent, informed investor. Whether you gather stock, equity, or company information via social media, traditional methods or word of mouth, we will assist in providing our subscribers with quality, timely and accurate information across various industries and sectors that will enhance your understanding and broaden your scope of knowledge.

Mindset Planning Trials for its Advanced Pre-Clinical Psychedelic MSP-1014!

The Investors Coliseum

Recent comments

The Investors Coliseum

Related tracks